Thursday, November 13, 2008
Morrisville, N.C.-based eClinical company etrials reported another quarter of loss, with net losses for the third quarter at $6.1 million, compared with $1.3 million for the same period last year and $2.2 million in net losses for the second quarter of 2008.
No Standard Policy for Conflicts of Interest
Philadelphia, Pa.-based eResearch Technology saw its revenue growth wane slightly in the third quarter but still maintained a 41.5% increase compared with the same period last year. The eClinical company reported net revenues for the quarter of $33.9 million up from $24 million in the third quarter of last year. Diluted net income per share was $0.13 compared with $0.07 in the third quarter of 2007, and gross margin was $19.1 million.
Trio of Companies in Strategic Outsourcing Partnerships with Lilly
U.S. disease foundations will invest about $90 million this year in biopharmaceutical companies to fund discovery and development of new drugs and therapies for their corresponding diseases, according to CenterWatch estimates.
A year after going public on the New York Stock Exchange, Chinese contract research, development and manufacturing company WuXi PharmaTech reported second quarter net revenues of $70.8 million—a 134% increase compared with the same period last year.